This promotes recruitment of immunosuppressive tumor-associated macrophages (TAMs), neutrophils, and myeloid-derived suppressor cells while excluding cytotoxic CD8+ T cells—often through downregulation of T-cell attractants—resulting in an immune desert phenotype that protects residual disease and confers resistance to immune checkpoint inhibitors [88]. This evidence concerns the gene CD8A and neoplasm.